Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 238,214,894 papers from all fields of science
Search
Sign In
Create Free Account
CBP 501
Known as:
CBP-501
, CBP501
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Cdc25C phosphatase (211-221)
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Cancer Therapy : Clinical Phase I Studies of CBP 501 , a G 2 Checkpoint Abrogator , as Monotherapy and in Combination with Cisplatin in Patients with Advanced Solid Tumors
G. Shapiro
,
R. Tibes
,
+18 authors
Sunil Sharma
2011
Corpus ID: 9340533
Purpose: Two phase I dose-escalation studies were conducted to determine themaximum tolerated dose (MTD) and safety profile of…
Expand
2008
2008
Phase I studies of CBP501, a novel G2 checkpoint abrogator, alone and combined with cisplatin (CDDP) in advanced solid tumor patients (pts)
Bryan Y. Wong
,
G. Shapiro
,
+7 authors
Sunil Sharma
2008
Corpus ID: 74517303
2528 Background: Most cancer cells are dependent on the G2 checkpoint to survive with DNA damage. The stable peptide CBP501 shows…
Expand
2008
2008
Gateways to clinical trials. July-August 2008.
A. Tomillero
,
M. A. Moral
Methods and Findings in Experimental and Clinical…
2008
Corpus ID: 23111308
(-)-Epigallocatechin gallate, 501516, 89-12; Abatacept, Adalimumab, Adefovir dipivoxil, AG-701, Agatolimod sodium, Alefacept…
Expand